Radiation Oncology
 |
| The
C.R. Wood Cancer Center uses
a new Varian linear accelerator with
state-of-the-art Intensity Modulated Radiation Therapy (IMRT). |
Radiation Oncology services at the C.R. Wood Cancer Center are provided
by a dedicated group of health care professionals,
including radiation oncologists, physicists, radiation therapists and
nurses. All of who are board-certified in their respective fields.
The department is equipped with state-of-the-art
technology, including two accelerators, a
CT/simulator, a number of treatment planning systems and access to a
positron emission tomographic scanner (PET/CT scanner). A high-dose rate
applicator (HDR) is scheduled for installation in 2006. The accelerators
are computer-controlled and are used to deliver
x-ray beam or electron beam radiotherapy. The accelerators are fitted with
the latest features including multi-leaf collimation and digital imaging.
This technology delivers fast and accurate treatment as well as
intensity-modulated radiotherapy (IMRT) and
image-guided
radiotherapy (IGRT). The PET/CT scanner produces metabolic
images of the body that permits image-fusion planning. Image-fusion planning
is the latest development in radiotherapy treatment planning that allows the
oncologist to better target tumors and avoid normal tissues.
In addition to accelerator-based radiotherapy, which is referred to as
external beam radiotherapy, the radiation oncology department has an active
brachytherapy or implant therapy service. Brachytherapy is a form of
radiotherapy in which small radioactive sources are placed directly into or
near a tumor. Cancers of the endometrium, cervix and
prostate are all currently
treated with brachytherapy at the C.R. Wood Cancer Center. The addition of
the HDR unit in 2006 will allow the expansion of the implant service to
include breast, esophageal and lung cancer.
Lastly, the department also has a radiopharamaceutical service.
Radiopharmaceuticals are used to treat thyroid cancer and some bone
cancers. Radioimmunotherapy (RIT) is the newest form of radiopharmaceutical
therapy. It uses an antibody specific to a certain tumor to deliver a
radiopharmaceutical to the cancer in order to destroy it. RIT has great
potential to eradicate certain cancers with minimal side effects. We have
been providing RIT at the C.R. Wood Cancer Center since 2004.
Radiation Oncologists